He, Kai
https://orcid.org/0000-0001-9905-5906
Mayo Clinic
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Citations 1
535 EVEREST-2: a phase 1/2 study of A2B694, a logic-gated Tmod CAR T therapy to treat solid tumors expressing mesothelin (MSLN) with HLA-A*02 loss of heterozygosity: initial safety and efficacy results
Hecht, J. Randolph, Spencer, Kristen , Marar, Rosalyn, Avila, Monica , Patel, Sandip Pravin , Maloney, David G. , Ulrickson, Matthew L. , Neal, Joel M, He, Kai , Go, William Y., Mitchell, Jasmine , Lou, Yanyan, Kundranda, Madappa N. , Mardiros, Armen, Bretzlaff, William, Xuan, Jacqueline D, Welch, John S. , Molina, Julian R. , Ward, Jeffrey P. , Kirtane, Kedar , Garon, Edward B. , Creelan, Ben , Maus, Marcela V , Eng, Cathy , Hazim, Antonious , Warner, Allison Betof , Neal, Joel M, Dorigo, Oliver , Vu, Peter , Xuan, Jacqueline D, Wise, Andrea, Ng, Eric W, Punekar, Salman R.
Regular and Young Investigator Award Abstracts | November 10, 2025 | Volume: No volume available | Issue: No issue available | Pages: A611-A612
